Holobiome
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$9M
Holobiome is a biotechnology company developing next-generation probiotics targeting the gut-brain axis to treat depression.
Focus Areas
Biotechnology
gut-brain axis
probiotics
depression
human testing
Investors
